| THIS MESSAGE BOARD IS NO LONGER ACTIVE.
TO SEE OUR ACTIVE MESSAGE BOARDS, PLEASE GO HERE |
| | CLL
[ Back to Messages
Posted by shirley
on January 24, 2000 at 13:46:38:
Rituxacin, manufactured by the Novartis Pharmaceutical company, has had at least a 50% success rate in putting B cell-CLL patients into complete remission. In the past, it had been used on B cell-lymphoma. My brother-in-law has B-cell CLL and was treated with Rituxacin in November-December 1999 and is now in complete remission.
All times are GMT -7. The time now is 07:11 AM.